MarketScreener Strategies StemRIM

Stocks

Market Closed - Japan Exchange 02:30:00 2026-08-26 EDT			5-day change	1st Jan Change
351.00 ^JPY	-0.57%		+2.33%	+33.46%

07-22	Stemrim Announces Patent Registration in Mexico for Redasemtide as Therapeutic Agent for Cartilage Disorders	CI
07-08	StemRIM Inc. Announces Patent Registration For Stem Cell Gene Therapy Technology SR-GT1 Aimed At Curative Treatment Of Dystrophic Epidermolysis Bullosa In South Korea	CI